Surmodics reported $752.34M in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbott ABT:US $ 205.99B 6.31B
Align Technology ALGN:US $ 48.35B 5.5B
Anika Therapeutics ANIK:US $ 623M 38.49M
Arrowhead Research ARWR:US $ 8.62B 1.74B
Baxter International BAX:US $ 40.48B 2.18B
Bioscrip BIOS:US $ 3.93B 742.82M
Boston Scientific BSX:US $ 60.76B 5.86B
Cryolife CRY:US $ 1.11B 227.06M
Edap Tms EDAP:US 207M 38.25M
Edwards Lifesciences EW:US $ 64.38B 12.15B
Genmark Diagnostics GNMK:US $ 1.05B 37.91M
Haemonetics HAE:US $ 3.4B 2.25B
Heron Therapeutics HRTX:US $ 1.58B 98.85M
Johnson & Johnson JNJ:US $ 433825.66M 1140.33M
Merit Medical Systems MMSI:US $ 3.62B 286.03M
Mesa Laboratories MLAB:US $ 1.39B 144.44M
Nektar Therapeutics NKTR:US $ 3.13B 515.22M
Oxford Immunotec Global OXFD:US 303.75M 33.67M
Providence Service PRSC:US $ 2.38B 282.32M
Stryker SYK:US $ 97.85B 6.08B
Surmodics SRDX:US $ 752.34M 18.94M
Trinity Biotech TRIB:US 61.45M 17.14M